Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data

被引:36
|
作者
Kepka, Deanna [1 ,2 ,4 ]
Spigarelli, Michael G.
Warner, Echo L. [1 ,2 ]
Yoneoka, Yukiko [3 ]
McConnell, Nancy [3 ]
Balch, Alfred H. [4 ]
机构
[1] Univ Utah, Coll Nursing, 10 S 2000 E, Salt Lake City, UT 84112 USA
[2] Huntsman Canc Inst, Canc Control & Populat Sci, 2000 Circle Hope,Room 4144, Salt Lake City, UT 84112 USA
[3] Utah Dept Hlth, Utah Statewide Immunizat Informat Syst, 288 N 1460 W, Salt Lake City, UT 84116 USA
[4] Univ Utah, Dept Pediat, Div Clin Pharmacol, 100 N Mario Capecchi Dr, Salt Lake City, UT 84132 USA
来源
PAPILLOMAVIRUS RESEARCH | 2016年 / 2卷
基金
美国国家卫生研究院;
关键词
HPV vaccine; Adolescent; Preventive medicine; Demographic factors; Registries;
D O I
10.1016/j.pvr.2016.06.002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Human papillomavirus (HPV) vaccine 3-dose completion rates among adolescent females in the US are low. Missed opportunities impede HPV vaccination coverage. Methods: A population-based secondary data analysis of de-identified vaccination and demographic data from the Utah Statewide Immunization Information System (USIIS) was conducted. Records were included from 25,866 females ages 11-26 years at any time during 2008-2012 who received at least one of the following adolescent vaccinations documented in the USIIS: Tdap (Tetanus, Diphtheria, Pertussis), meningococcal, and/or influenza. A missed opportunity for HPV vaccination was defined as a clinical encounter where the patient received at least one adolescent vaccination, but not a HPV vaccine. Results: Of 47,665 eligible visits, there were 20,911 missed opportunities (43.87%). Age group, race/ethnicity, and rurality were significantly associated with missed opportunity (p < 0.0001). In a multi variable mixed-effects logistic regression model that included ethnicity, location and age, as fixed effects and subject as a random effect, Hispanics were less likely to have a missed opportunity than whites OR 0.59 (95% CI: 0.52-0.66), small rural more likely to have a missed opportunity than urban youth OR 1.8 (95% CI: 1.5-2.2), and preteens more likely than teens OR 2.4 (95% CI: 2.2-2.7). Conclusion: Missed clinical opportunities are a significant barrier to HPV vaccination among female adolescents. Interventions targeted at providers who serve patient groups with the highest missed opportunities are needed to achieve adequate protection from HPV-associated illnesses. Impact: This is one of the first studies to utilize state immunization information system data to assess missed opportunities for HPV vaccination. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:128 / 132
页数:5
相关论文
共 50 条
  • [1] Human Papillomavirus Vaccine: Continuation, Completion, and Missed Opportunities
    Richards, Molly J.
    Peters, Marissa
    Sheeder, Jeanelle
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2016, 29 (02) : 117 - 121
  • [2] Human Papillomavirus Vaccine Coverage and Prevalence of Missed Opportunities for Vaccination in an Integrated Healthcare System
    Irving, Stephanie A.
    Groom, Holly C.
    Stokley, Shannon
    McNeil, Michael M.
    Gee, Julianne
    Smith, Ning
    Naleway, Allison L.
    ACADEMIC PEDIATRICS, 2018, 18 (02) : S85 - S92
  • [3] Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
    Zhou, Xu
    Sun, Lihua
    Yao, Xiaoxiao
    Li, Guangquan
    Wang, Yicun
    Lin, Yang
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [4] Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review
    Ellingson, Mallory K.
    Sheikha, Hassan
    Nyhan, Kate
    Oliveira, Carlos R.
    Niccolai, Linda M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [5] Human papillomavirus vaccination in adults: impact, opportunities and challenges – a meeting report
    Dur-e-Nayab Waheed
    John Schiller
    Margaret Stanley
    Eduardo L. Franco
    Mario Poljak
    Susanne K. Kjaer
    Marta del Pino
    Fiona van der Klis
    Maarten F. Schim van der Loeff
    Marc Baay
    Pierre Van Damme
    Alex Vorsters
    BMC Proceedings, 15 (Suppl 7)
  • [6] Opportunities for Increasing Human Papillomavirus Vaccine Provision in School Health Centers
    Moss, Jennifer L.
    Feld, Ashley L.
    O'Malley, Brittany
    Entzel, Pamela
    Smith, Jennifer S.
    Gilkey, Melissa B.
    Brewer, Noel T.
    JOURNAL OF SCHOOL HEALTH, 2014, 84 (06) : 370 - 378
  • [7] Increasing Human Papillomavirus Vaccination Rates Among Adolescents: Overcoming Vaccine Hesitancy and Using Practice Improvements
    Shawhan, Andrew
    Ruppe, Rebekah L.
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2019, 15 (08): : 559 - 563
  • [8] Viral Hepatitis and Human Papillomavirus Vaccination During HIV Pre-Exposure Prophylaxis: Factors Associated With Missed Vaccination
    Raccagni, Angelo Roberto
    Ceccarelli, Daniele
    Trentacapilli, Benedetta
    Galli, Laura
    Lolatto, Riccardo
    Canetti, Diana
    Bruzzesi, Elena
    Candela, Caterina
    Castagna, Antonella
    Nozza, Silvia
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 93 (05) : 351 - 355
  • [9] Asking about human papillomavirus vaccination and the usefulness of registry validation: A study of young women recruited using Facebook
    Gunasekaran, Bharathy
    Jayasinghe, Yasmin
    Brotherton, Julia M. L.
    Fenner, Yeshe
    Moore, Elya E.
    Wark, John D.
    Fletcher, Ashley
    Tabrizi, Sepehr N.
    Garland, Suzanne M.
    VACCINE, 2015, 33 (06) : 826 - 831
  • [10] Update on barriers to human papillomavirus vaccination and effective strategies to promote vaccine acceptance
    Bratic, Julia S.
    Seyferth, Elisabeth R.
    Bocchini, Joseph A., Jr.
    CURRENT OPINION IN PEDIATRICS, 2016, 28 (03) : 407 - 412